Header cover image

Chinese (SSE) Healthcare Sector Analysis

UpdatedFeb 21, 2025
DataAggregated Company Financials
Companies470
  • 7D3.3%
  • 3M-0.3%
  • 1Y0.1%
  • YTD4.8%

The Healthcare industry is up 3.3% in the last week, with WuXi AppTec up 13%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 26% per annum.

Sector Valuation and Performance

Has the Chinese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 21 Feb 2025CN¥5.7tCN¥2.2tCN¥153.7b33.3x37.3x2.6x
Sun, 19 Jan 2025CN¥5.3tCN¥2.2tCN¥153.7b30.5x34.8x2.4x
Tue, 17 Dec 2024CN¥5.9tCN¥2.2tCN¥153.7b34.5x38.2x2.6x
Thu, 14 Nov 2024CN¥6.2tCN¥2.2tCN¥154.1b34.8x40x2.7x
Sat, 12 Oct 2024CN¥5.7tCN¥2.2tCN¥161.8b32.1x35.2x2.5x
Mon, 09 Sep 2024CN¥4.9tCN¥2.2tCN¥162.1b27.2x30.1x2.2x
Wed, 07 Aug 2024CN¥5.2tCN¥2.3tCN¥166.1b29.1x31.4x2.3x
Fri, 05 Jul 2024CN¥5.0tCN¥2.3tCN¥165.0b26.9x30.3x2.2x
Sun, 02 Jun 2024CN¥5.7tCN¥2.3tCN¥167.8b30.4x33.8x2.5x
Tue, 30 Apr 2024CN¥5.9tCN¥2.3tCN¥173.8b32.1x33.9x2.6x
Thu, 28 Mar 2024CN¥5.7tCN¥2.3tCN¥179.6b29.3x31.9x2.5x
Sat, 24 Feb 2024CN¥5.8tCN¥2.3tCN¥179.9b28.8x32.3x2.5x
Mon, 22 Jan 2024CN¥6.0tCN¥2.3tCN¥176.9b31.3x33.7x2.6x
Wed, 20 Dec 2023CN¥6.4tCN¥2.3tCN¥177.1b34.4x36.4x2.8x
Fri, 17 Nov 2023CN¥6.6tCN¥2.3tCN¥177.2b35.6x37.4x2.9x
Sun, 15 Oct 2023CN¥6.6tCN¥2.3tCN¥185.1b34.1x35.5x2.9x
Tue, 12 Sep 2023CN¥6.2tCN¥2.3tCN¥186.5b31.8x33.3x2.7x
Thu, 10 Aug 2023CN¥6.4tCN¥2.3tCN¥193.3b32.3x33.2x2.8x
Sat, 08 Jul 2023CN¥6.5tCN¥2.3tCN¥191.9b33.4x33.8x2.9x
Mon, 05 Jun 2023CN¥6.9tCN¥2.3tCN¥191.4b35.6x35.8x3x
Wed, 03 May 2023CN¥7.1tCN¥2.3tCN¥199.7b37x35.5x3.1x
Fri, 31 Mar 2023CN¥7.0tCN¥2.2tCN¥233.5b36.7x30.1x3.1x
Sun, 26 Feb 2023CN¥7.3tCN¥2.2tCN¥233.0b39x31.1x3.3x
Tue, 24 Jan 2023CN¥7.4tCN¥2.2tCN¥233.3b37.8x31.9x3.4x
Thu, 22 Dec 2022CN¥6.7tCN¥2.2tCN¥231.9b35x28.9x3.1x
Sat, 19 Nov 2022CN¥7.3tCN¥2.2tCN¥231.7b39.9x31.3x3.3x
Mon, 17 Oct 2022CN¥6.7tCN¥2.1tCN¥227.5b34.7x29.3x3.2x
Wed, 14 Sep 2022CN¥6.5tCN¥2.1tCN¥222.2b33.3x29.3x3.1x
Fri, 12 Aug 2022CN¥6.6tCN¥2.1tCN¥228.1b33.2x29.1x3.2x
Sun, 10 Jul 2022CN¥7.0tCN¥2.1tCN¥224.6b34.3x31.3x3.4x
Tue, 07 Jun 2022CN¥6.4tCN¥2.0tCN¥226.1b33.2x28.1x3.1x
Thu, 05 May 2022CN¥6.2tCN¥2.0tCN¥230.9b29.7x26.7x3x
Sat, 02 Apr 2022CN¥7.0tCN¥2.0tCN¥214.9b35.1x32.6x3.6x
Mon, 28 Feb 2022CN¥7.0tCN¥1.9tCN¥208.9b35.8x33.7x3.6x
Price to Earnings Ratio

33.7x


Total Market Cap: CN¥7.0tTotal Earnings: CN¥208.9bTotal Revenue: CN¥1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Healthcare Sector Price to Earnings3Y Average 32.6x202320242025
Current Industry PE
  • Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 37.3x which is higher than its 3-year average PE of 32.6x.
  • The 3-year average PS ratio of 2.9x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 9.7% per year over the last three years.
  • Meanwhile revenues for these companies have grown 4.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare sector?

CN Market1.28%
Healthcare3.29%
Healthtech14.15%
Life Sciences11.55%
Healthcare Services4.96%
Medical Equipment4.80%
Biotech4.09%
Pharma0.39%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 375x.
    • Analysts are expecting annual earnings growth of 47.1%, which is higher than its past year's earnings decline of 19.7% per year.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading close to its 3-year average of 29.5x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 47% over the next 5 years.
  • This is better than its past earnings decline of 20% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 19% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
603259 WuXi AppTecCN¥68.4115.0%
+CN¥25.8b
27.7%PE24.5x
600276 Jiangsu Hengrui MedicineCN¥48.286.1%
+CN¥17.7b
13.9%PE56.3x
688506 Sichuan Biokin PharmaceuticalLtdCN¥209.4314.7%
+CN¥10.7b
80.9%PE22.1x
300347 Hangzhou Tigermed ConsultingCN¥61.5910.5%
+CN¥5.0b
40.5%PE55x
300759 Pharmaron BeijingCN¥29.339.6%
+CN¥4.6b
32.4%PE27.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

603259

CN¥68.41

WuXi AppTec

7D

15.0%

1Y

27.7%

300122

CN¥26.85

Chongqing Zhifei Biological Products

7D

5.3%

1Y

-49.4%

002252

CN¥6.77

Shanghai RAAS Blood Products

7D

-3.8%

1Y

-4.2%

601607

CN¥19.66

Shanghai Pharmaceuticals Holding

7D

-2.7%

1Y

9.3%